Early High-Dose Methylprednisolone Therapy Is Associated with Better Outcomes in Children with Acute Necrotizing Encephalopathy

Background: The neurologic outcomes of acute necrotizing encephalopathy (ANE) are very poor, with a mortality rate of up to 40% and fewer than 10% of patients surviving without neurologic deficits. Steroid and immunoglobulin treatments have been the most commonly used options for ANE, but their ther...

Full description

Bibliographic Details
Main Authors: Han-Pi Chang, Shao-Hsuan Hsia, Jainn-Jim Lin, Oi-Wa Chan, Chun-Che Chiu, En-Pei Lee
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/9/2/136
_version_ 1797481782569861120
author Han-Pi Chang
Shao-Hsuan Hsia
Jainn-Jim Lin
Oi-Wa Chan
Chun-Che Chiu
En-Pei Lee
author_facet Han-Pi Chang
Shao-Hsuan Hsia
Jainn-Jim Lin
Oi-Wa Chan
Chun-Che Chiu
En-Pei Lee
author_sort Han-Pi Chang
collection DOAJ
description Background: The neurologic outcomes of acute necrotizing encephalopathy (ANE) are very poor, with a mortality rate of up to 40% and fewer than 10% of patients surviving without neurologic deficits. Steroid and immunoglobulin treatments have been the most commonly used options for ANE, but their therapeutic efficacy is still controversial. Method: We retrospectively reviewed the medical records of 26 children diagnosed with ANE. We also divided these patients into two groups: 21 patients with brainstem involvement and 8 patients without brainstem involvement. Pulse steroid therapy (methylprednisolone at 30 mg/kg/day for 3 days) and intravenous immunoglobulin (2 g/kg for 2–5 days) were administered to treat ANE. Results: The overall mortality rate was 42.3%, and patients who did not survive had significantly higher initial lactate and serum ferritin levels, as well as higher rates of inotropic agent use with brainstem involvement. There were no significant differences in the outcomes of pulse steroid therapy or pulse steroid plus immunoglobulin between survivors and non-survivors. When analyzing the time between symptom onset and usage of pulse steroid therapy, pulse steroid therapy used within 24 h after the onset of ANE resulted in significantly better outcomes (<i>p</i> = 0.039). In patients with brainstem involvement, the outcome was not correlated with pulse steroid therapy, early pulse steroid therapy, or pulse steroid therapy combined with immunoglobulin. All patients without brainstem involvement received “early pulse methylprednisolone” therapy, and 87.5% (7/8) of these patients had a good neurologic outcome. Conclusion: Pulse steroid therapy (methylprednisolone at 30 mg/kg/day for 3 days) administered within 24 h after the onset of ANE may be correlated with a good prognosis. Further studies are needed to establish a consensus guideline for this fulminant disease.
first_indexed 2024-03-09T22:19:27Z
format Article
id doaj.art-aa53f6d6917a4fa5a448cb0902fb0ade
institution Directory Open Access Journal
issn 2227-9067
language English
last_indexed 2024-03-09T22:19:27Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series Children
spelling doaj.art-aa53f6d6917a4fa5a448cb0902fb0ade2023-11-23T19:18:02ZengMDPI AGChildren2227-90672022-01-019213610.3390/children9020136Early High-Dose Methylprednisolone Therapy Is Associated with Better Outcomes in Children with Acute Necrotizing EncephalopathyHan-Pi Chang0Shao-Hsuan Hsia1Jainn-Jim Lin2Oi-Wa Chan3Chun-Che Chiu4En-Pei Lee5Division of Pediatric Critical Care Medicine, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 33305, TaiwanDivision of Pediatric Critical Care Medicine, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 33305, TaiwanDivision of Pediatric Critical Care Medicine, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 33305, TaiwanDivision of Pediatric Critical Care Medicine, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 33305, TaiwanDivision of Pediatric Critical Care Medicine, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 33305, TaiwanDivision of Pediatric Critical Care Medicine, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan 33305, TaiwanBackground: The neurologic outcomes of acute necrotizing encephalopathy (ANE) are very poor, with a mortality rate of up to 40% and fewer than 10% of patients surviving without neurologic deficits. Steroid and immunoglobulin treatments have been the most commonly used options for ANE, but their therapeutic efficacy is still controversial. Method: We retrospectively reviewed the medical records of 26 children diagnosed with ANE. We also divided these patients into two groups: 21 patients with brainstem involvement and 8 patients without brainstem involvement. Pulse steroid therapy (methylprednisolone at 30 mg/kg/day for 3 days) and intravenous immunoglobulin (2 g/kg for 2–5 days) were administered to treat ANE. Results: The overall mortality rate was 42.3%, and patients who did not survive had significantly higher initial lactate and serum ferritin levels, as well as higher rates of inotropic agent use with brainstem involvement. There were no significant differences in the outcomes of pulse steroid therapy or pulse steroid plus immunoglobulin between survivors and non-survivors. When analyzing the time between symptom onset and usage of pulse steroid therapy, pulse steroid therapy used within 24 h after the onset of ANE resulted in significantly better outcomes (<i>p</i> = 0.039). In patients with brainstem involvement, the outcome was not correlated with pulse steroid therapy, early pulse steroid therapy, or pulse steroid therapy combined with immunoglobulin. All patients without brainstem involvement received “early pulse methylprednisolone” therapy, and 87.5% (7/8) of these patients had a good neurologic outcome. Conclusion: Pulse steroid therapy (methylprednisolone at 30 mg/kg/day for 3 days) administered within 24 h after the onset of ANE may be correlated with a good prognosis. Further studies are needed to establish a consensus guideline for this fulminant disease.https://www.mdpi.com/2227-9067/9/2/136methylprednisoloneneurologic outcomesmortalitychildrenacute necrotizing encephalopathy
spellingShingle Han-Pi Chang
Shao-Hsuan Hsia
Jainn-Jim Lin
Oi-Wa Chan
Chun-Che Chiu
En-Pei Lee
Early High-Dose Methylprednisolone Therapy Is Associated with Better Outcomes in Children with Acute Necrotizing Encephalopathy
Children
methylprednisolone
neurologic outcomes
mortality
children
acute necrotizing encephalopathy
title Early High-Dose Methylprednisolone Therapy Is Associated with Better Outcomes in Children with Acute Necrotizing Encephalopathy
title_full Early High-Dose Methylprednisolone Therapy Is Associated with Better Outcomes in Children with Acute Necrotizing Encephalopathy
title_fullStr Early High-Dose Methylprednisolone Therapy Is Associated with Better Outcomes in Children with Acute Necrotizing Encephalopathy
title_full_unstemmed Early High-Dose Methylprednisolone Therapy Is Associated with Better Outcomes in Children with Acute Necrotizing Encephalopathy
title_short Early High-Dose Methylprednisolone Therapy Is Associated with Better Outcomes in Children with Acute Necrotizing Encephalopathy
title_sort early high dose methylprednisolone therapy is associated with better outcomes in children with acute necrotizing encephalopathy
topic methylprednisolone
neurologic outcomes
mortality
children
acute necrotizing encephalopathy
url https://www.mdpi.com/2227-9067/9/2/136
work_keys_str_mv AT hanpichang earlyhighdosemethylprednisolonetherapyisassociatedwithbetteroutcomesinchildrenwithacutenecrotizingencephalopathy
AT shaohsuanhsia earlyhighdosemethylprednisolonetherapyisassociatedwithbetteroutcomesinchildrenwithacutenecrotizingencephalopathy
AT jainnjimlin earlyhighdosemethylprednisolonetherapyisassociatedwithbetteroutcomesinchildrenwithacutenecrotizingencephalopathy
AT oiwachan earlyhighdosemethylprednisolonetherapyisassociatedwithbetteroutcomesinchildrenwithacutenecrotizingencephalopathy
AT chunchechiu earlyhighdosemethylprednisolonetherapyisassociatedwithbetteroutcomesinchildrenwithacutenecrotizingencephalopathy
AT enpeilee earlyhighdosemethylprednisolonetherapyisassociatedwithbetteroutcomesinchildrenwithacutenecrotizingencephalopathy